Skip to main content
Clinical Trials/JPRN-jRCTs031220227
JPRN-jRCTs031220227
Recruiting
Phase 2

Enhancement of healing after arthroscopic rotator cuff repair by PFC-FD(Platelet-Derived Factor Concentrate Freeze Dry) - PFC-FD for Promotion of Rotator Cuff Healing

SHITARA HITOSHI0 sites20 target enrollmentJuly 28, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
SHITARA HITOSHI
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 28, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
SHITARA HITOSHI

Eligibility Criteria

Inclusion Criteria

  • (1\) 20 years old and older
  • (2\) Subjects who have a diagnosed with rotator cuff tears.
  • (3\) Subjects whose tears are classified as middle size tears and greater than that by the Cofield's classification.
  • (4\) Subjects who are scheduled to undergo arthroscopic shoulder rotator cuff repair.
  • (5\) Subjects who have given written consent to participate in this study.

Exclusion Criteria

  • 1\) Subjects with preoperative platelets \< 150,000 microliters
  • 2\) Subjects with hematologic disorders or coagulopathy
  • 3\) Subjects who need to continue anticoagulants (anticoagulants) in the perioperative period
  • 4\) Subjects with tumors
  • 5\) Subjects who are infected with various blood disease viruses (HBV/HCV/HIV/HTLV\-1\)
  • 6\) Subjects who have received PRP or PFC\-FD therapy to the same area within 3 months
  • 7\) Subjects who are pregnant
  • 8\) Subjects who are breast\-feeding
  • 9\) Subjects with contraindications to MRI imaging
  • 10\) Other subjects who are judged as inappropriate subjects by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials